PMV Pharmaceuticals, Inc closed fiscal year 2025 with $116.6M in total assets, $11.8M in total liabilities and $104.7M in shareholder equity. Total assets fell 39.1% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters PMV Pharmaceuticals, Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PMVP Balance Sheet by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-Q | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-Q | FY1810-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $116.6M-39.1% | $191.3M-24.1% | $252.2M-6.7% | $270.3M-18.5% | $331.6M-9.3% | $365.5M+254.8% | $103.0M | N/A |
| Total Liabilities | $11.8M-22.1% | $15.2M-42.5% | $26.5M+9.0% | $24.3M+5.5% | $23.0M+259.0% | $6.4M-96.3% | $173.5M | N/A |
| Total Equity | $104.7M-40.5% | $176.1M-22.0% | $225.7M-8.3% | $246.0M-20.3% | $308.6M-14.1% | $359.1Mn/m | -$70.5Mn/m | -$46.1M |
PMVP Balance Sheet by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'25Filing | Q4'2410-K | Q3'2410-Q | Q2'24Filing | Q1'24Filing | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $111.4M-16.8% | $82.1M-46.3% | $96.6M-43.4% | $116.6M-39.1% | $133.8M-40.1% | $152.9M-35.7% | $170.6M-28.0% | $191.3M-24.1% | $223.5M-14.4% | $237.5M-1.9% | $236.9M-6.7% | $252.2M-6.7% |
| Total Liabilities | $54.3M+322.7% | $10.6M-13.7% | $8.6M-18.2% | $11.8M-22.1% | $12.8M-49.8% | $12.3M-47.3% | $10.5M-56.6% | $15.2M-42.5% | $25.6M+9.3% | $23.2M-4.8% | $24.2M+1.7% | $26.5M+9.0% |
| Total Equity | $57.1M-52.8% | $71.5M-49.1% | $88.0M-45.1% | $104.7M-40.5% | $121.0M-38.9% | $140.6M-34.4% | $160.1M-24.7% | $176.1M-22.0% | $197.9M-16.7% | $214.3M-1.6% | $212.7M-7.6% | $225.7M-8.3% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More PMV Pharmaceuticals, Inc financials
Frequently Asked Questions
PMV Pharmaceuticals, Inc closed fiscal year 2025 with $116.6M in total assets, $11.8M in total liabilities and $104.7M in shareholder equity.
PMV Pharmaceuticals, Inc (PMVP) total assets fell by 39.1% year over year, from $191.3M to $116.6M in fiscal year 2025.
PMV Pharmaceuticals, Inc (PMVP) reported $111.4M in total assets in Q3 2026. This represents a decrease of 16.8% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what PMV Pharmaceuticals, Inc (PMVP) reported on that line in every period on record.